New technologies to quality control and selection of stem cells

for applications in regenerative medicine and cell therapy

Winner

Is it best sample we can ever inject?

QC matters!Stem cells QC & production for Regenerative Medicine

Market Cell Therapy New Era

2500

1500

500

Increase x20

2012 2016 2018

Market forecast(million $)

Organ regeneration$ 350 billion

Regenerative Medicine$ 100 billion

Market2015 Technologies

$ 118 millions

Stem cells$ 1.3 billion

US

• No manipulations of cells

• Costs, process times reduction

• Passing regulatory barriers

Lab R&D

Cell banks

Cell factories

ClinicsHospitals

Clinical Surgery

Clients&Needs

Exclusive features

No cell manipulation

High purity

High cell recovery

Real time monitoring

Our solutionA novel method to tag-less isolate and sort living cells

Celector®

Concept&Prototype

WHAT WE NEEDMarketing, Sales, and Business Scale-up Partners

Towards the ready-to-marketProduct Development, Finance, Investments

1st VC investment- 200k

Debt capital- 20k UNINDUSTRIA- 20k CARISBO

Debt capital- 190k CARISBO

POR “innovative start-up”- 190k ER 2nd VC investment

- 400k

R&D

Validation

Industrialization

Foundation € 1 M Today

The CompanyManagers, R&D team, and Equity

Academics73.67%

VC15%

Incubator11.33%Foundation

Academics45.68%

VC47.30%

Incubator7.02%

Today

Martina Rossi BiotechnologistApplications Developer

Ilaria VigliottaBiotechnologistProduct Developer

Silvia ZiaBiomedical ScientistApplications Manager

Marco VaglivielloMechanical EngineerProduct Manager

Prof. Pierluigi ReschiglianCEO

Prof. Barbara Roda

Prof. Andrea Zattoni

Dr. M. LuisaNolliProject Manager